Insurers

Inside pharma's trust problem

Inside pharma's trust problem

By

Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?

PBMs, drugmakers face off over copay accumulators

PBMs, drugmakers face off over copay accumulators

By

As with most drug pricing battles, patients yet again are caught in the crossfire.

High-profile candidates challenge marketers well in advance of launch

High-profile candidates challenge marketers well in advance of launch

By

With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

By

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

Five things for pharma marketers to know: Thursday, January 18, 2018

Five things for pharma marketers to know: Thursday, January 18, 2018

By

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

Five things for pharma marketers to know: Tuesday, January 16, 2018

Five things for pharma marketers to know: Tuesday, January 16, 2018

By By

Merck's Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark's Luxturna overpriced, ICER says

Five things for pharma marketers to know: Tuesday, December 26, 2017

Five things for pharma marketers to know: Tuesday, December 26, 2017

By

Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations

Five things for pharma marketers to know: Tuesday, December 19, 2017

Five things for pharma marketers to know: Tuesday, December 19, 2017

By

Pharma industry spent $57 million on lobbying in 2016; Humana, private equity firms to buy Kindred for $4 billion; price of old glaucoma drug skyrockets

Five things for pharma marketers to know: Monday, December 18, 2017

Five things for pharma marketers to know: Monday, December 18, 2017

By

CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter's Vraylar sees positive results for bipolar depression

CVS/Aetna Moves Healthcare M&A Beyond Cost and into Disruption

CVS/Aetna Moves Healthcare M&A Beyond Cost and into Disruption

This time around the M&A moves will be much bigger in scope, promising to reconfigure the complex and fragile healthcare payer/provider/patient ecosystem.

 Five things for pharma marketers to know: Thursday, December 7, 2017

Five things for pharma marketers to know: Thursday, December 7, 2017

By

UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval

Five things for pharma marketers to know: Monday, December 4, 2017

Five things for pharma marketers to know: Monday, December 4, 2017

By

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

Five things for pharma marketers to know: Monday, November 27, 2017

Five things for pharma marketers to know: Monday, November 27, 2017

By

Teva to cut thousands of U.S. jobs; Regeneron drops Eylea combo drug development; insurers, drugstores, and hospitals increasingly teaming up

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

By

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Monday, September 18, 2017

Five things for pharma marketers to know: Monday, September 18, 2017

By

Insurers rarely require prior authorization for opioids; court of appeals voids J&J win in Advil ads suit; new California law to address drug pricing

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

By

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Five things for pharma marketers to know: Thursday, July 27, 2017

Five things for pharma marketers to know: Thursday, July 27, 2017

By

Generic drugmakers reportedly seeking deals; GSK to refocus R&D; Merck and AstraZeneca to test combo cancer drug

Five things for pharma marketers to know: Friday, May 5, 2017

Five things for pharma marketers to know: Friday, May 5, 2017

By

CVS formulary changes lifted Tresiba sales; Novartis licenses NASH drug; FDA is building digital health unit

Five things for pharma marketers to know: Monday, April 10, 2017

Five things for pharma marketers to know: Monday, April 10, 2017

By

Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose

Dr. Vidya Raman-Tangella, UnitedHealthcare

Dr. Vidya Raman-Tangella, UnitedHealthcare

Dr. Vidya Raman-Tangella is head of the UHC innovation center of excellence.

Jay Rajda, Aetna

Jay Rajda, Aetna

Jay Rajda is chief clinical transformation officer and senior medical director for clinical innovation and health and clinical services at Aetna.

Geeta Wilson, Humana

Geeta Wilson, Humana

Geeta Wilson is VP of consumer experience at Humana.

Five things for pharma marketers to know: Monday, March 20, 2017

Five things for pharma marketers to know: Monday, March 20, 2017

By

Study finds SGLT-2 inhibitors lowered risk of death; former FDA commissioners raise drug importation issues; Bayer, J&J's Xarelto lowered VTE risk in study

Five things for pharma marketers to know: Friday, March 10, 2017

Five things for pharma marketers to know: Friday, March 10, 2017

By

Novartis' Gleevec shows long-term survival benefit in study; Novo Nordisk CEO considers small acquisitions; Merck KGaA to sell biosimilars unit

Cigna partners with Microsoft HoloLens on biometric game

Cigna partners with Microsoft HoloLens on biometric game

By

The health insurer partnered with Microsoft to use VR and AR technology to gather biometric data.

Five things for pharma marketers to know: Wednesday, February 15, 2017

Five things for pharma marketers to know: Wednesday, February 15, 2017

By

Pharma execs raise concerns about Trump's plans for the FDA; Merck ends study of experimental Alzheimer's drug; Amgen seeks new indication for Blincyto

Infographic: What payers want from pharma

Infographic: What payers want from pharma

One pharmacy director would like to see a lot more comparative data about new therapies.

Five things for pharma marketers to know: Tuesday, January 10, 2017

Five things for pharma marketers to know: Tuesday, January 10, 2017

By

Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval

Five things for pharma marketers to know: Tuesday, December 13, 2016

Five things for pharma marketers to know: Tuesday, December 13, 2016

By

Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant

Five things for pharma marketers to know: Monday, November 7, 2016

Five things for pharma marketers to know: Monday, November 7, 2016

By

Bayer submits Stivarga to FDA for liver-cancer indication; emails show FDA's divisiveness over Duchenne drug approval; insurers want new president to address ACA financial risks